ABSCIENCES (EPA:AB)

09/05/2023 18:06

AB Science announces that Health Canada has resumed its review of the New Drug Submission for masitinib in amyotrophic lateral sclerosis, following issuance of a screening acceptance letter

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

27/04/2023 20:41

AB Science - Summary of the presentation on masitinib in ALS delivered at 2023 AAN Annual Meeting

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

21/04/2023 22:26

AB Science announces the implementation of a new strategy and the launch of a capital increase

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

15/03/2023 18:05

AB Science will host a live webcast on its microtubule destabilizer agents (MDA) platform on Thursday March 16, 2023, from 6pm to 7pm CET

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

13/03/2023 18:09

AB Science reports a first complete bone marrow response in a relapsed refractory acute myeloid leukemia patient from the very low dose arm of its AB8939 Phase I/II clinical trial (AB18001)

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

28/02/2023 08:03

AB Science announced the publication of the masitinib pivotal phase 3 clinical trial in Alzheimer’s Disease in the journal Alzheimer's Research & Therapy

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

29/12/2022 18:08

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

27/12/2022 19:04

Masitinib receives orphan drug status for the treatment of amyotrophic lateral sclerosis in Switzerland

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

13/12/2022 18:08

AB Science receives Notice of Deficiency (NOD) from Health Canada for masitinib in the treatment of amyotrophic lateral sclerosis (ALS)

Display more news published by ABSCIENCES

ABSCIENCES (EPA:AB)

21/11/2022 18:09

AB Science receives U.S. Food and Drug Administration (FDA) authorization to initiate confirmatory Phase 3 clinical study with masitinib in the treatment of Alzheimer’s Disease

Display more news published by ABSCIENCES

«
1
2
3
4
5
6
7
8
9
10

Other stories

04/05/2024 03:30

Tories take refuge in fantasy as local election drubbing becomes clear - The Guardian

03/05/2024 16:59

Lord Ben Houchen 'absolutely' willing to work with Starmer if Tories lose general election - Sky News

03/05/2024 23:54

London mayor election: Voter turnout 40.5% - BBC.com

04/05/2024 04:48

Local election results 2024: Mayoral results due after Labour notches up key wins - BBC

04/05/2024 00:19

Judge unmasks three teenagers who killed schoolboy at 16th birthday house party - The Independent

03/05/2024 19:45

Anger over Gaza clouds Labour's local election wins - Financial Times

03/05/2024 19:47

Hainault sword attack victim thanks NHS and family for saving his life - The Guardian

03/05/2024 10:34

Pro-Palestinian protests spread across British universities - The Telegraph

03/05/2024 15:22

A mixed weekend of sunshine and showers - Met Office

03/05/2024 17:53

Alfie Lewis: Teenager found guilty of murdering boy, 15, in Leeds - BBC

03/05/2024 22:45

Canada charges three Indian nationals with murder of Sikh separatist - Financial Times

03/05/2024 22:08

Ex-aide Hope Hicks gets emotional during Trump trial testimony - BBC

03/05/2024 21:35

Brazil: 37 killed and dozens missing in worst floods in 80 years - The Guardian

03/05/2024 14:55

Germany's FM says Russia will face consequences for 'intolerable' cyberattack - FRANCE 24 English

03/05/2024 22:51

Blow to motorists as cost of fuel rises AGAIN due to tensions in Middle East... - The Sun

04/05/2024 00:49

US stocks rally as cooling labour market boosts rate cut hopes - Financial Times

03/05/2024 13:18

Gazprom sees worst loss in decades as European exports falter - Euronews

03/05/2024 18:22

FTSE 100 Live: Index closes at another record amid weak US jobs figures - Evening Standard

03/05/2024 11:07

Sony Xperia 10 VI revealed with design changes and fewer cameras than Xperia 10 V - Notebookcheck.net

03/05/2024 23:21

Worst-ever interviews: 'They told us to crawl and moo' - BBC

02/05/2024 20:18

Apple working to fix iPhone alarm problem - The Guardian

03/05/2024 16:34

Ferrari unveil powerful new supercar to replace discontinued model – & it’ll hit over 200 mph... - The Sun

04/05/2024 03:32

Kevin Spacey denies new allegations of inappropriate behaviour - Sky News

03/05/2024 21:00

How BBC bosses convinced James Corden and Ruth Jones to turn down seven-figure Netflix bid for last ever... - The Sun

03/05/2024 22:15

Olly Murs issues apology to Take That fans after missing gig due to airport drama - Manchester Evening News

04/05/2024 04:26

SmackDown: May 3, 2024 - WWE

04/05/2024 03:30

Adrian Newey exit could spark Red Bull exodus, predicts McLaren chief - The Guardian

04/05/2024 01:43

Winners and losers from an odd Miami F1 sprint qualifying - The Race

04/05/2024 00:00

Postecoglou confident Tottenham back him to make 'drastic change' in rebuild - Evening Standard

03/05/2024 19:48

Man City out to surpass 103-year-old unbeaten record in Wolves clash - Sports Mole

03/05/2024 14:02

China launches Chang’e-6 probe to study dark side of the moon - Al Jazeera English

04/05/2024 04:15

How to watch the Eta Aquariid meteor shower this weekend - Sky News

03/05/2024 14:42

CO2 removal ‘gap’ shows countries ‘lack progress’ for 1.5C warming limit - Carbon Brief

03/05/2024 20:22

Boeing Starliner spacecraft 'go' for 1st astronaut launch on May 6, NASA says - Space.com

04/05/2024 03:30

Leprosy passed between medieval squirrels and humans, study suggests - The Guardian

03/05/2024 01:44

'Life-changing' sickle cell disease treatment made available on NHS - Sky News

03/05/2024 17:40

Bird flu outbreak in US cattle sparks fears over next global health crisis - Financial Times

03/05/2024 17:53

How Ozempic caused a disgusting side effect that left this YouTuber in 'absolute agony' - Daily Mail